Query opportunities in oncology

We have a small oncology unit. Our CDI nurse is looking for any help in identifying query opportunities for oncology patients. Besides the usual queries (AKI, respiratory failure, CHF, pancytopenia, etc) are there any common things to look for regarding oncology. Are there any resources we could access?

Comments

  • Often see drug-induced pancytopenia charted as a consequence of High Dose Interleukin 2.   All 3 elements decline very abruptly, but query often warranted to confirm pancytopenia.


    Bile Duct malignant stricture and obstruction in conjunction w/ Primary Ca of Biliary System is also area of focus - look at ERCP.

    Paul Evans, RHIA, CCDS

  • -Underlying cause of pleural effusions and ascites - ? malignant
    -Malnutrition
    -If the patient has had a stem cell or bone marrow transplant, is their admitting diagnosis a complication of this transplant?
    -Colitis/diarrhea secondary to chemo/immunotherapy drugs
    -Sepsis/bacteremia related to chemo central lines (Ports, Hickmans, etc)
    -Acuity of Pulmonary Edema from IVF

    Hope this helps!

    Sarah Simone, BSN RN CCDS
  • What are your clinical indicators for chemo -induced pancytopenia. Does it have to entail a neutropenia or does leukopenia suffice. AHIMA supports an ANC <1,500 HCT <32 PLATELETS <150K. Many attendings don't endorse neutropenia, and pancytopenia is doc with total wbc counts <4. I'm afraid this will be a red flag for RAC.    Any thoughts?  
  • Cerebral edema from Metastasis -- review CT/MRI -- check for treatment (IV decadron, PO decadron). 

  • pdx question:  Patient admitted with difficulty breathing, after study patient found to have bilateral pleural effusions, underwent thoracentesis bilateral.  The provider documented malignant pleural effusions, patient does have known lung cancer.  Can the pdx be the lung cancer?  Or would we need to go with Acute respiratory failure as pdx, this was also documented/treated upon admission. 

  • i find the biggest issue with these records is truly understanding what is being to treated and the underlying etiology to assure correct sequencing. Review your coding guidelines to assure you are asking the correct questions in these instances. (especially related to anemia and other complications of the neoplasm. Secondly- for risk adjustment the specificity of the malignancy related to metastases, identified lymph nodes involved, acuity of leukemia are very important. 
Sign In or Register to comment.